A myth of ophthalmic beta-blockers therapy

Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1721; author reply 1723. doi: 10.1007/s00417-009-1164-9. Epub 2009 Aug 20.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Accidental Falls / statistics & numerical data*
  • Administration, Topical
  • Adrenergic beta-Antagonists / administration & dosage*
  • Adrenergic beta-Antagonists / adverse effects
  • Antihypertensive Agents / administration & dosage*
  • Antihypertensive Agents / adverse effects
  • Blood Pressure / drug effects
  • Glaucoma / drug therapy*
  • Heart Rate / drug effects
  • Humans
  • Hypotension, Orthostatic / epidemiology*
  • Hypotension, Orthostatic / etiology
  • Intraocular Pressure / drug effects
  • Ocular Hypertension / drug therapy
  • Ophthalmic Solutions / administration & dosage
  • Ophthalmic Solutions / adverse effects
  • Risk Assessment
  • Surveys and Questionnaires

Substances

  • Adrenergic beta-Antagonists
  • Antihypertensive Agents
  • Ophthalmic Solutions